v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING EXPENSES    
Research and development expenses $ 119,525 $ 28,346
General and administrative expenses 366,358 412,062
Total operating expenses 485,883 440,408
LOSS FROM OPERATIONS (485,883) (440,408)
LOSS, BEFORE TAX (485,883) (440,408)
Income tax benefit (expense)
NET LOSS $ (485,883) $ (440,408)
Net loss per share attributable to common stockholders, basic $ (0.03) $ (0.03)
Net loss per share attributable to common stockholders, diluted $ (0.03) $ (0.03)
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, basic 16,072,267 12,723,721
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted 16,072,267 12,723,721
NET LOSS $ (485,883) $ (440,408)